Co-Authors
This is a "connection" page, showing publications co-authored by Jean-Charles Soria and Fabrice Barlesi.
Connection Strength
0.963
-
A patient reported outcome platform, a useful tool to improve monitoring and effective management of Covid-19-positive patients with cancer. Eur J Cancer. 2020 06; 132:1-4.
Score: 0.219
-
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies. Br J Cancer. 2017 Jun 06; 116(12):1505-1512.
Score: 0.179
-
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet. 2016 Apr 02; 387(10026):1415-1426.
Score: 0.163
-
Severe COVID-19 in patients with hematological cancers presenting with viremia. Ann Oncol. 2021 10; 32(10):1297-1300.
Score: 0.060
-
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis. Cell Death Differ. 2021 12; 28(12):3297-3315.
Score: 0.060
-
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic. Cancer Cell. 2021 08 09; 39(8):1039-1041.
Score: 0.059
-
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021 03 11; 12(3):258.
Score: 0.058
-
Author Correction: Caring for patients with cancer in the COVID-19 era. Nat Med. 2020 07; 26(7):1146.
Score: 0.056
-
Caring for patients with cancer in the COVID-19 era. Nat Med. 2020 05; 26(5):665-671.
Score: 0.055
-
Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med. 2020 06; 8(6):542-544.
Score: 0.055